BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31824762)

  • 1. Dynamic changes in prescription opioids from 2006 to 2017 in Texas.
    Ighodaro EO; McCall KL; Chung DY; Nichols SD; Piper BJ
    PeerJ; 2019; 7():e8108. PubMed ID: 31824762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid distribution trends (2006-2017) in the US Territories.
    Cabrera FF; Gamarra ER; Garcia TE; Littlejohn AD; Chinga PA; Pinentel-Morillo LD; Tirado JR; Chung DY; Pande LJ; McCall KL; Nichols SD; Piper BJ
    PeerJ; 2019; 7():e6272. PubMed ID: 30671308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Declines and regional variation in opioid distribution by U.S. hospitals.
    Eidbo SA; Kropp Lopez AK; Hagedorn JD; Mathew V; Kaufman DE; Nichols SD; McCall KL; Piper BJ
    Pain; 2022 Jun; 163(6):1186-1192. PubMed ID: 34510133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in adverse drug events of opioids in the United States.
    Liu EY; McCall KL; Piper BJ
    Front Pharmacol; 2023; 14():1163976. PubMed ID: 37033633
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011.
    Atluri S; Sudarshan G; Manchikanti L
    Pain Physician; 2014; 17(2):E119-28. PubMed ID: 24658483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining but Pronounced State-Level Disparities in Prescription Opioid Distribution in the United States.
    Madera JD; Ruffino AE; Feliz A; McCall KL; Davis CS; Piper BJ
    Pharmacy (Basel); 2024 Jan; 12(1):. PubMed ID: 38251408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic analysis and data mining of opioid-related adverse events submitted to the FAERS database.
    Le H; Hong H; Ge W; Francis H; Lyn-Cook B; Hwang YT; Rogers P; Tong W; Zou W
    Exp Biol Med (Maywood); 2023 Nov; 248(21):1944-1951. PubMed ID: 38158803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription Opioid Distribution after the Legalization of Recreational Marijuana in Colorado.
    Kropp Lopez AK; Nichols SD; Chung DY; Kaufman DE; McCall KL; Piper BJ
    Int J Environ Res Public Health; 2020 May; 17(9):. PubMed ID: 32392702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Medical Use of Opioids in the U.S., 2006-2016.
    Piper BJ; Shah DT; Simoyan OM; McCall KL; Nichols SD
    Am J Prev Med; 2018 May; 54(5):652-660. PubMed ID: 29551331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the Distribution of Opioids in Puerto Rico, 1999-2013.
    El Burai Félix S; Mack KA; Jones CM
    P R Health Sci J; 2016 Sep; 35(3):165-9. PubMed ID: 27623143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioids for cancer pain - an overview of Cochrane reviews.
    Wiffen PJ; Wee B; Derry S; Bell RF; Moore RA
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012592. PubMed ID: 28683172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective analysis of the impact of Michigan's opioid prescribing legislation on discharge opioid prescribing at a single institution.
    Sadowski R; Hillaker E; Chavarria M; Khaliq F; Schwark A
    J Opioid Manag; 2022; 18(5):467-474. PubMed ID: 36226786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000-2010.
    Kenan K; Mack K; Paulozzi L
    Open Med; 2012; 6(2):e41-7. PubMed ID: 23696768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in analgesic exposures reported to Texas Poison Centers following increased regulation of hydrocodone.
    Haynes A; Kleinschmidt K; Forrester MB; Young A
    Clin Toxicol (Phila); 2016 Jun; 54(5):434-40. PubMed ID: 26919555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
    Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
    JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry.
    Smith ML; Hughes RO; Levine B; Dickerson S; Darwin WD; Cone EJ
    J Anal Toxicol; 1995; 19(1):18-26. PubMed ID: 7536861
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.